Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 51–100 of 4,123 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03698994	Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)	active not recruiting	Phase 2	20	National Cancer Institute (NCI)NIH	2	Sep 21, 2026	clinicaltrials
NCT06005740	A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer	active not recruiting	Phase 1	70	TORL Biotherapeutics, LLCINDUSTRY	2	Sep 21, 2026